ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2126

Time Trends In Total Ankle Arthroplasty: A Study Of The U.S. National Inpatient Sample

Jasvinder A. Singh1,2 and Rekha Ramachandaran3, 1Rheumatology, Birmingham VA, Birmingham, AL, 2Department of Medicine, University of Alabama, Tuscaloosa, AL, 3University of Alabama at Birmingham, Birmingham, AL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankle, Arthroplasty, epidemiologic methods and utilization review

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Orthopedics, Low Back Pain and Rehabilitation

Session Type: Abstract Submissions (ACR)

Background/Purpose: To assess the time-trends in utilization, clinical characteristics and outcomes of patients undergoing total ankle arthroplasty (TAA) in the U.S.

Methods: We used the Nationwide Inpatient Sample (NIS) data from 1998 to 2010 to examine time-trends in TAA. Rates were calculated for the U.S. population. We used the Cochran Armitage test for trend to test for trend across the years.   We compared the first and the last period for trends using, ANOVA and chi-squared test as appropriately.

Results:   TAA utilization rate increased from 0.12 per 100,000 in 1998 to 0.84 per 100,000 in 2010. The Cochran Armitage test for trend across years yielded a significant p-value of <0.0001. In females and males, the rate increased from 0.14 to 0.88 per 100,000 (p<0.0001 for time-trend) and from 0.11 to 0.81 per 100,000 (p<0.0001 for time-trend), respectively. Compared to the 1998-99, significantly fewer patients <50 years (37% fewer) and more patients ≥80 years (85% higher) in 2009-10 underwent TAA (p <0.0001).  Compared to 1998-99, RA was less frequently the underlying diagnosis (55% reduction) and a greater proportion of patients had Deyo-Charlson index of 2 or more (33% more) in 2009-10. Comparing 1998-99 to 2009-10, we noted a slight decrease in the length of stay from 2.7 to 2.5 days (17% reduction), slight increase in the proportion of patients being discharged to inpatient facility from 12.9% to 14.1% (12% increase) and no change in mortality, 0.13% to 0.12% (9% decrease). 

Conclusion: The utilization rate of TAA is rapidly increasing in the U.S. Underlying diagnosis and medical comorbidity has changed over time that can impact the type and frequency of complications after TAA.  Further studies are needed to assess how the outcomes and complications of TAA have evolved over time.


Disclosure:

J. A. Singh,

Takeda, Savient,

2,

Savient, Takeda, Ardea, Regeneron, Allergan,

5,

URL pharmaceuicals Novartis,

5;

R. Ramachandaran,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/time-trends-in-total-ankle-arthroplasty-a-study-of-the-u-s-national-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology